Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

L.A. McKeown

February 23, 2024

News Daily News

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

L.A. McKeown

March 31, 2023

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

Subclinical Atherosclerosis Common in General Population, Even Those With Zero CAC

Yael L. Maxwell

September 24, 2021

News Daily News

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

Michael O'Riordan

February 06, 2020

News Daily News

Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events

Marcus A. Banks

July 25, 2019

News Daily News

CV Risk Factors in Youth May Prove Indelible for Later CAD

Marcus A. Banks

July 17, 2019

News Conference News EAS 2019

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Michael O'Riordan

June 05, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Industry News

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

November 01, 2016

News Daily News

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Michael O'Riordan

August 23, 2016

News Daily News

Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows

Michael O'Riordan

April 14, 2016

News Daily News

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

Michael O'Riordan

December 13, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

Advertisement

Side Effects of Statins Might Be Overstated: CTT Collaboration

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

Good News and Bad for High-Intensity Statin Use in ASCVD

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Subclinical Atherosclerosis Common in General Population, Even Those With Zero CAC

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events

CV Risk Factors in Youth May Prove Indelible for Later CAD

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content